Evidence map›Paper›PMID 35983092›Full record

ArticleFrontiers in medicine2022

Performance of quantitative measurements in [

Nicolas Jacquet-Francillon, Isabelle Morelec, Natacha Germain, Jean-Michel Prades, Vincent Habouzit, Christophe Mariat, Pierre-Benoit Bonnefoy, Nathalie Prevot

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Nicolas Jacquet-FrancillonDepartment of Nuclear Medicine, Saint-Étienne University Hospital, University of Saint-Étienne, Saint-Étienne, France.
Isabelle MorelecDepartment of Nuclear Medicine, Hospices Civils de Lyon, Lyon, France.
Natacha GermainDivision of Endocrinology, Diabetes, Metabolism and Eating Disorders, Centre Hospitalo-Universitaire (CHU) de Saint-Étienne, Saint-Étienne, France.
Jean-Michel PradesDepartment of Otorhinolaryngology, Head and Neck Surgery, Hospital Saint-Étienne, Saint-Étienne, France.
Vincent HabouzitDepartment of Nuclear Medicine, Saint-Étienne University Hospital, University of Saint-Étienne, Saint-Étienne, France.
Christophe MariatDepartment of Nephrology, Dialysis and Renal Transplantation, Hôpital Nord, Centre Hospitalo-Universitaire (CHU) de Saint-Étienne, Jean Monnet University, Université de Lyon, Saint-Étienne, France.
Pierre-Benoit BonnefoyDepartment of Nuclear Medicine, Saint-Étienne University Hospital, University of Saint-Étienne, Saint-Étienne, France.
Nathalie PrevotDepartment of Nuclear Medicine, Saint-Étienne University Hospital, University of Saint-Étienne, Saint-Étienne, France.
Centre Hospitalier Universitaire de Saint-Étienne · FRUniversité Claude Bernard Lyon 1 · FRHospices Civils de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: [ Materials and methods: In two academic centers, we retrospectively included patients with biological hyperparathyroidism (HPT) and who had [ Results: The quantitative criteria in [ Conclusion: Semi-quantitative measurements (SUV

Indexed as

[18F]fluorocholineadenomahyperplasiaparathyroidPET/CTPTHsemi quantitative analysisSUV

Identifiers

PMID35983092
PMCPMC9380568
OpenAlexW4289524511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.